![]() Citizens and patients will be involved in the development of the system. The project aims to deliver a decision support system for improved and more rapid diagnosis and prognosis. DRAGON - Rapid and secure AI imaging based diagnosis, stratification, follow-up, and preparedness for coronavirus pandemics.This low-cost, diagnostic system that will make it possible to test patients with laboratory quality performance almost anywhere in 15 minutes or less. DECISION - A miniaturised disposable molecular diagnostics platform for combatting coronavirus infections.Led by Universitair Medisch Centrum Utrecht (NL) The project will combine expertise in clinical epidemiology with digital devices (such as wearables and mobile apps) to rapidly and reliably detect cases, so that patients can be prioritised for testing. COVID-RED - COVID-19 infections: remote early detection.On, following the independent evaluation of proposals, it was announced that 8 projects were short-listed for funding, including on 5 projects receiving €28 million in EU grants to develop rapid diagnostics: On 3 March 2020, the Innovative Medicines Initiative (IMI) supported through the European Commission’s Horizon 2020 Framework Programme for Research and Innovation, launched a special fast-track call for the “Development of therapeutics and diagnostics combatting coronavirus infections” with an EU contribution of €45 million, which was subsequently increased to €72 million. Special Innovative Medicines Initiative call (May 2020) Testimonial from Gary Keating (Chief Technology Officer at HiberGene Diagnostics, Dublin).Story: Rapid COVID-19 test granted EU approval.Story: PCR, antigen and antibody: Five things to know about coronavirus tests.Story: Devices for rapid diagnosis of coronavirus under developmentĭevelopment and validation of rapid molecular diagnostic test for nCoV19, that does not require virus extraction chemistry, with a particular focus on early stage disease diagnosis.Led by Danmarks Tekniske Universitet (DK). Three Rapid Diagnostic tests (Point-of-Care) for COVID-19 Coronavirus, improving epidemic preparedness, public health and socio-economic benefits, that can be used with minimal training. Story: COVID-19 diagnose faster and cheaper.Led by Fundacio Institut Catala de Nanociencia i Nanotecnologia (ES). The project will develop a rapid point-of-care diagnosis and monitoring, and also monitor the evolution of viruses in animals and help prevent future outbreaks. ![]() Among these, 3 projects are receiving a total of €6.4 million to develop effective, rapid point-of-care diagnostics: CoNVatĬombating 2019-nCoV: Advanced Nanobiosensing platforms for POC global diagnostics and surveillance. The projects, which involve 151 teams across Europe and beyond, have started working on improving epidemiology and public health, including preparedness and response to outbreaks, diagnostic tests, new treatments and new vaccines. In January 2020, the Commission launched an emergency call, through which €48.2 million were awarded to 18 research projects. New projects 1st Horizon 2020 call for expression of interest (March 2020) - €117 million granted for treatments and diagnostics through the ΙΜΙ.– Newly-funded project brings new rapid diagnostic to the market.The following is an overview of how the EU is already supporting the development of coronavirus diagnostic tests. ![]() Diagnostic tests, especially point-of-care, are essential to enable front-line health workers to make the diagnosis quickly and accurately, as well as to reduce the risk of further spread of the virus. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |